Piper Sandler analyst Adam Maeder reiterated an Overweight rating and $4.50 price target on InspireMD (NASDAQ: NSPR).The analyst commented, "This ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE